1. Binimetinib, pemetrexed and cisplatin, followed by maintenance of binimetinib and pemetrexed in patients with advanced non-small cell lung cancer (NSCLC) and KRAS mutations. The phase 1B SAKK 19/16 trial. (June 2021) Authors: Froesch, Patrizia; Mark, Michael; Rothschild, Sacha I.; Li, Qiyu; Godar, Gilles; Rusterholz, Corinne; Oppliger Leibundgut, Elisabeth; Schmid, Sabine; Colombo, Ilaria; Metaxas, Yannis; König, David; Sessa, Cristiana; Gautschi, Oliver; Früh, Martin Journal: Lung cancer Issue: Volume 156(2021) Page Start: 91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Characterization of the properties of a selective, orally bioavailable autotaxin inhibitor in preclinical models of advanced stages of liver fibrosis. (17th January 2018) Authors: Baader, Manuel; Bretschneider, Tom; Broermann, Andre; Rippmann, Joerg F; Stierstorfer, Birgit; Kuttruff, Christian A; Mark, Michael Journal: British journal of pharmacology Issue: Volume 175:Number 4(2018) Page Start: 693 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Combination of cisplatin and lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma: Report of two cases. (December 2016) Authors: Metaxas, Yannis; Cathomas, Richard; Mark, Michael; von Moos, Roger Journal: Lung cancer Issue: Volume 102(2016) Page Start: 136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Differences in kidney-specific DPP-4 inhibition by linagliptin and sitagliptin. (September 2018) Authors: Luippold, Gerd; Mark, Michael; Klein, Thomas; Amann, Kerstin; Daniel, Christoph Journal: Diabetes research and clinical practice Issue: Volume 143(2018) Page Start: 199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Estimating the economic effects of university-industry collaboration. (2014) Authors: Mark, Michael; Jensen, Rasmus Lund; Norn, Maria Theresa Journal: International journal of technology transfer and commercialisation Issue: Volume 13:Number 1/2(2014) Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Fibroblast growth factor receptor (FGFR) inhibitor rogaratinib in patients with advanced pretreated squamous-cell non-small cell lung cancer over-expressing FGFR mRNA: The SAKK 19/18 phase II study. (October 2022) Authors: Addeo, Alfredo; Rothschild, Sacha I.; Holer, Lisa; Schneider, Martina; Waibel, Christine; Haefliger, Simon; Mark, Michael; Fernandez, Eugenio; Mach, Nicolas; Mauti, Laetitia; Jermann, Philip M.; Alborelli, Ilaria; Calgua, Byron; Savic-Prince, Spasenija; Joerger, Markus; Früh, Martin Journal: Lung cancer Issue: Volume 172(2022) Page Start: 154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. LA velocities and stasis assessed by 4D flow MRI are closely associated with LAA peak velocities by Doppler TEE in patients with atrial fibrillation. Issue 1 (December 2016) Authors: Mark, Michael; Furiasse, Nicholas; Lee, Daniel; Ng, Jason; Carr, James; Goldberger, Jeffrey Journal: Journal of cardiovascular magnetic resonance Issue: Volume 18:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Orteronel Switch Maintenance Therapy in Metastatic Castration Resistant Prostate Cancer After First‐Line Docetaxel: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Trial (SAKK 08/11). Issue 16 (25th July 2016) Authors: Cathomas, Richard; Crabb, Simon J.; Mark, Michael; Winterhalder, Ralph; Rothermundt, Christian; Elliott, Tony; von Burg, Philippe; Kenner, Heike; Hayoz, Stefanie; Vilei, Simona Berardi; Rauch, Daniel; Roggero, Enrico; Mohaupt, Markus G.; Bernhard, Jürg; Manetsch, Gabriela; Gillessen, Silke Journal: Prostate Issue: Volume 76:Issue 16(2016) Page Start: 1519 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Quantifying endogeneity of cryptocurrency markets. Issue 7 (3rd May 2022) Authors: Mark, Michael; Sila, Jan; Weber, Thomas A. Journal: European journal of finance Issue: Volume 28:Issue 7(2022) Page Start: 784 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. RE: Real-World Use of Bone Modifying Agents in Metastatic Castration-Sensitive Prostate Cancer. (29th November 2021) Authors: Mark, Michael; von Moos, Roger; Cathomas, Richard; Stoffel, Sandro; Gillessen, Silke Journal: Journal of the National Cancer Institute Issue: Volume 114:Number 4(2022) Page Start: 635 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗